Curcumin, hemostasis, thrombosis, and coagulation
Citations Over TimeTop 10% of 2017 papers
Abstract
Atherothrombotic cardiovascular disease is a major cause of mortality throughout the world. Platelet activation and aggregation play a central role in hemostasis and thrombosis. Herbal medicines have been traditionally used in the management of cardiovascular disease and can help in modifying its progression, particularly in hemostasis and the coagulation process, as well as altering platelet function tests and some coagulation parameters. Curcumin is a polyphenol derived from the Curcuma longa plant and has been used extensively in complementary and alternative medicine, as it is nontoxic and safe with various therapeutic properties. Modern scientific research has demonstrated its anti-inflammatory, antioxidant, anti-carcinogenic, antithrombotic, and cardiovascular protective effects. The present study reviewed previous studies in the literature, which support the positive activity of curcumin in hemostasis, anticoagulation, and fibrinolysis. We also presented molecular mechanisms associated with the antiplatelet and anticoagulant activities of curcumin and potential implications for the treatment of cardiovascular disease.
Related Papers
- → Physiologic mechanisms of hemostasis and fibrinolysis(1989)9 cited
- Anti Oxidant Potential of “Cureit”- A Novel BioAvailable Curcumin Formulation(2014)
- → Transfusion Management of Patients Receiving Antithrombotic Therapy(2018)2 cited
- → Metabolic Fate of Curcumin in the Gastrointestinal Tract in Mice(2016)1 cited
- → Evaluation of Curcumin Nanoparticles against Rabbit Skin Infection(2023)